Page 10 - Ldl News Today

The cloud computing industry is riding the wave of tech's comeback in 2023, putting CLDL in the green year-to-date.

A medical expert discusses preauthorization requests and requirements for cardiovascular disease treatment, commenting on an abstract presented at the ACC 2023 Annual Scientific Session and Expo and World Congress of Cardiology.

Hypercholesterolemia impact on cardiovascular outcomes is explored by a key opinion leader.

Dr Michos offers strategies to successfully reduce LDL levels in patients with cardiovascular disease.

Erin Michos, MD, MHS, opens a discussion surrounding the utilization of bempedoic acid for patients with intolerance to statin-based therapies.

In their final thoughts, Drs Brinton, Baum and Michos provide insights on the trajectory of treatment in HoFH.

Dr. Saima Zafar, a cardiologist with Texas Health Kaufman, tells KERA’s Sam Baker why statins don't work for some, and what makes Nexletol an acceptable alternative.

For decades, the answer to lowering cholesterol to prevent heart attack or stroke was a statin prescription. Unfortunately, ...

Group of supreme court justices in history will gather to hear on whether affirmative action in supreme college admissions is constitutional. -- a real chance of dismantling affirmative action altogether. joining me, dwight mcbride, president of the new school and -- senior counsel at the legal defense fund. thank you both very much for coming to the sunday show. michelle, i will start with you. the ldl wrote amicus brief in this case, representing 25 students and alumni groups. any anticipation...

These were last week’s top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework.